CheKine™ Micro Albumin Content Assay Kit: Your Buyer's Guide for Clinical-Grade Accuracy in Preclinical Research

The 30-Second Verdict

Albumin—the most abundant plasma protein (35-50 g/L in healthy adults)—serves as a definitive biomarker for renal function, liver health, nutritional status, and vascular integrity[reference:75][reference:76]. Abbkine's CheKine™ Micro Albumin (Alb) Content Assay Kit (KTB2221) combines bromocresol green (BCG) dye-binding chemistry with a microplate-based format, requiring just 2–10 µL of sample, a wide dynamic range (2–56 mg/mL), and results in under 30 minutes[reference:77]. The global albumin assay market, valued at over $1.2 billion in 2024, is projected to grow at a CAGR of 4.8% through 2030—and KTB2221 is engineered to bridge the gaps in accuracy, accessibility, and applicability that plague the industry[reference:78][reference:79].

Pros

✅ Microvolume design — only 10–20 µL sample per assay (70-80% reduction)[reference:80]

✅ Wide dynamic range — 2–56 mg/mL[reference:81]

✅ Exceptional specificity — proprietary modified BCP chromogenic system; cross-reactivity <1.8%[reference:82]

✅ Rapid workflow — results in under 30 minutes[reference:83]

✅ Broad sample compatibility — serum, plasma, urine[reference:84]

✅ Minimal interference — optimized at pH 4.2 to minimize interference from globulins, bilirubin, hemoglobin, and lipids[reference:85][reference:86]

✅ Clinical-grade accuracy — aligns with CDC reference methods

Cons

❌ Requires standard microplate reader

❌ Not for clinical diagnosis (research use only)

Who Should Buy This Kit?

Ideal for:

• Hepatology researchers studying liver fibrosis, cirrhosis, and hepatocellular carcinoma[reference:87]
• Nephrology researchers assessing diabetic nephropathy and glomerular damage[reference:88]
• Drug development teams studying drug-protein binding and pharmacokinetics[reference:89]
• Nutritional researchers monitoring protein-energy malnutrition[reference:90]
• Labs working with precious limited-volume samples: pediatric patients, rare clinical specimens, primary cell supernatants, small-animal serum[reference:91]
• Researchers conducting high-throughput screening campaigns[reference:92]

Skip this if:

• You lack a microplate reader
• You need albumin measurement in non-biological samples

How It Works: The Optimized Bromocresol Green Dye-Binding Method

The kit employs a well-established but optimized BCG dye-binding method: at a specific pH, BCG binds selectively to albumin, producing a color change that is quantified spectrophotometrically[reference:93]. Unlike classic BCG-based kits that cross-react with globulins, bilirubin, and hemoglobin—leading to overestimation of albumin by up to 15-20%—the KTB2221 uses a proprietary modified chromogenic system, optimized to bind specifically to albumin while excluding interference[reference:94].

Why Sample Volume Matters

Traditional assays typically demand 50–100 μL of sample per reaction[reference:95]. This poses a critical barrier for pediatric patients (small blood volumes), rare clinical specimens (e.g., cerebrospinal fluid), or research samples like primary cell supernatants[reference:96]. KTB2221's microvolume design expands utility to low-volume samples and enables multiple analyses from a single aliquot, maximizing the value of precious biological material[reference:97].

The Bottom Line

For researchers and clinicians who need accurate albumin quantification without sample waste, interference artifacts, or cumbersome protocols, KTB2221 delivers the specificity (<1.8% cross-reactivity), sensitivity (2-56 mg/mL range), and speed (under 30 minutes) that modern translational research demands. Whether you're modeling liver fibrosis, assessing nephropathy, or studying drug-protein binding, this kit turns albumin quantification from a bottleneck into a streamlined workflow[reference:98].

👉 Quantify albumin with confidence. View Product